StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Cantor Fitzgerald Reiterates Overweight Rating on Johnson & Johnson (JNJ) Following Court Decision
April 28, 2020 6:53 AM
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $168.00 price target on Johnson & Johnson (NYSE: JNJ) following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Litigation
Next Articles
UBS Downgrades Johnson & Johnson (JNJ) to Neutral
April 28, 2020 4:47 AM
Federal Judge Excludes Certain Plaintiff Expert Testimony from Talc Ovarian Cancer Trials, Deeming Them Not Scientifically Sound
April 27, 2020 6:44 PM
U.S. judge rules talc lawsuits against J&J can proceed, testimony limited
April 27, 2020 3:13 PM
Special Report: Countries, companies risk billions in race for coronavirus vaccine
April 25, 2020 3:37 PM
